Study Summary
This trial will evaluate a new device to treat prostate cancer in men with intermediate-risk Gleason Grade Group 2.
- Prostate Cancer
Treatment Effectiveness
Effectiveness Progress
Study Objectives
2 Primary · 1 Secondary · Reporting Duration: 36 months
Trial Safety
Safety Progress
Trial Design
1 Treatment Group
Vanquish System Treatment
1 of 1
Experimental Treatment
400 Total Participants · 1 Treatment Group
Primary Treatment: Vanquish System Treatment · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · Male Participants · 9 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Is there any capacity to join this investigation currently?
"Affirmative. Clinicaltrials.gov confirms that this research program, which was initially posted on March 1st 2023 and most recently updated on March 8th 2023 is actively looking for participants. 400 patients are needed from one medical centre." - Anonymous Online Contributor
How numerous are the participants in this clinical experiment?
"Affirmative. Information available on clinicaltrials.gov shows that this medical trial is actively looking for participants to join, beginning with its initial posting date of March 1st 2023 and the most recent update being on March 8th 2023. 400 people are needed from single site in order to complete this study's recruitment process." - Anonymous Online Contributor